These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34568003)

  • 1. Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients.
    Liang N; Liu L; Huang C; Liu H; Guo C; Li J; Wang W; Li N; Lin R; Wang T; Ding L; Mao L; Li S
    Front Oncol; 2021; 11():647512. PubMed ID: 34568003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes.
    Yang J; Zhang B; Guan W; Fan Z; Pu X; Zhao L; Jiang W; Cai W; Quan X; Miao S; Nie L; He L
    Cancer Med; 2023 May; 12(9):10575-10586. PubMed ID: 36916520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
    Yamada Y
    Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed death-ligand 1 expression profiling in thymic epithelial cell tumors: Clinicopathological features and quantitative digital image analyses.
    Ishihara S; Okada S; Ogi H; Kodama Y; Shimomura M; Tsunezuka H; Itoh K; Marx A; Inoue M
    Lung Cancer; 2020 Jul; 145():40-47. PubMed ID: 32402921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of thymic epithelial tumors reveals critical genes underlying tumorigenesis and poor prognosis.
    Tan S; Chen J; Wang Z; Zhao X; Sun Y; Zhu Y; Gong Z; Zhang D
    Clin Genet; 2023 May; 103(5):529-539. PubMed ID: 36541162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic profile of thymic epithelial tumors in the Japanese population: an exploratory study examining potential therapeutic targets.
    Shimada M; Taniguchi H; Yamaguchi H; Gyotoku H; Sasaki D; Kaku N; Senju C; Senju H; Imamura E; Takemoto S; Yamamoto K; Sakamoto N; Obase Y; Tsuchiya T; Fukuda M; Soda H; Ashizawa K; Fukuoka J; Nagayasu T; Yanagihara K; Mukae H
    Transl Lung Cancer Res; 2023 Apr; 12(4):707-718. PubMed ID: 37197618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor.
    Yuan X; Huang L; Luo W; Zhao Y; Nashan B; Yu F; Liu Y
    Front Oncol; 2021; 11():708735. PubMed ID: 34778027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent Genetic Alterations and Their Clinical Significance in Patients With Thymic Epithelial Tumors.
    Xu S; Li X; Zhang H; Zu L; Yang L; Shi T; Zhu S; Lei X; Song Z; Chen J
    Front Oncol; 2021; 11():667148. PubMed ID: 34307137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational landscape of thymic epithelial tumors in a Chinese population: insights into potential clinical implications.
    Wang H; Xu X; Luo L; Wang C; Jiang Z; Lin Y
    Gland Surg; 2021 Apr; 10(4):1410-1417. PubMed ID: 33968692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic alterations in thymoma-molecular pathogenesis?
    Oberndorfer F; Müllauer L
    J Thorac Dis; 2020 Dec; 12(12):7536-7544. PubMed ID: 33447444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics, prognostic factors, and long-term outcomes associated with epithelial malignancies of the thymus: A 20-year single-institution experience.
    Altshuler E; Mathavan A; Mathavan A; Krekora U; Mathavan M; Hones K; Daily K
    Cancer Rep (Hoboken); 2023 Mar; 6(3):e1750. PubMed ID: 36369906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological significance of grading on thymic epithelial tumors].
    Chen G; Chen W; He W; Jiang Y; Zhou Y; Huang O
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):105-9. PubMed ID: 11866964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors.
    Song JS; Kim D; Kwon JH; Kim HR; Choi CM; Jang SJ
    Front Oncol; 2019; 9():1055. PubMed ID: 31681591
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
    Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD
    PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors.
    Chen Y; Zhang Y; Chai X; Gao J; Chen G; Zhang W; Zhang Y
    Biomed Res Int; 2018; 2018():5830547. PubMed ID: 29850538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique correlation between GTF2I mutation and spindle cell morphology in thymomas (type A and AB thymomas).
    Wells K; Lamrca A; Papaxoinis G; Wallace A; Quinn AM; Summers Y; Nonaka D
    J Clin Pathol; 2023 Jul; 76(7):463-466. PubMed ID: 35039450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations of thymic epithelial tumors with myasthenia gravis.
    Pardini E; Cucchiara F; Palumbo S; Tarrini G; Di Vita A; Coppedè F; Nicolì V; Guida M; Maestri M; Ricciardi R; Aprile V; Ambrogi MC; Barachini S; Lucchi M; Petrini I
    Front Oncol; 2023; 13():1224491. PubMed ID: 37671056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemistry for YAP1 N-terminus and C-terminus highlights metaplastic thymoma and high-grade thymic epithelial tumors by different staining patterns.
    Yamada Y; Küffer S; Sauer C; Hoki M; Shibuya S; Tsujii H; Ono K; Moriyoshi K; Date H; Yoshizawa A; Szolkowska M; Haga H; Ströbel P; Marx A
    Virchows Arch; 2024 Sep; 485(3):461-469. PubMed ID: 39096416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.